TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes of self-determination competence level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of exercise program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acceptability of exercises post-corticosteroid injection
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Integrated glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of decedents with presence of inflammation
Endpoint domain: Mortality/survival
Primary endpoint: Number of decedents with presence of fibrosis
Endpoint domain: Mortality/survival
Primary endpoint: Number of decedents with presence of thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Number of decedents with presence of necrosis
Endpoint domain: Mortality/survival
Primary endpoint: Oscillations related to pain in the EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Correlation of MRI signal intensity and glioma protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cataract lens hardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Referrals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Disease control without allograft loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative rate of intraocular pressure (IOP) spikes 30 mmHg or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean percent endothelial cell count (ECC) change preoperatively vs. postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in Short Health Scale-HD score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hemorrhoidal Disease Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Clinical Symptom Score in 1 Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Biochemical indicators in 1 Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Diagnostic Examination in 1 Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nocturnal alveolar hypoventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of DLT events and treatment emergent AEs (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Ketosis (adherence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in response bias (logb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean gait speed [m/s]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver Activity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total propofol dose in milligramme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: propofol site effect concentration in microgram per milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of oxygen requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic accuracy for staging of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue contour changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of JT001 and its metabolite 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of postoperative opioid administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neural activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Intensity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient response (RANO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of LB1901
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended dose for expansion (RDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in cognitive function test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ACL rupture relapse rate
Endpoint domain: Mortality/survival
Primary endpoint: Area under the plasma semaglutide concentration-time curve after a single dose divided by dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Chronic pain status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pericentral Visual Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Validation of Echo/CorLog PV-Loops
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: composite endpoint of cardiovascular and cerebrovascular diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of tumour infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Spiritual well-being level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cue-induced craving for chemsex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change of Corneal Endothelium Cells (CEC) density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of cardio-cerebrovascular diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of other non-communicable chronic diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of the calf muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cumberland Ankle Instability Test questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Star Excursion Proprioception Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface Electromyographic Measurements of the Suprahyoid Muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Adherence Persistence Over Weeks 1-8
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Adherence Persistence Over Weeks 8-16
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility - Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility - Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility - Intervention Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in facial nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tumor Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Days Alive and Ventilator-free Days
Endpoint domain: Mortality/survival
Primary endpoint: Positive diagnostic correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of all adverse events (AEs), serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of all adverse events (AEs), serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of abnormal laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard drinks per drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate without recurrence of atrial tachyarrhythmias
Endpoint domain: Mortality/survival
Primary endpoint: Glossopalatine junction opening and closing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Velopharyngeal junction opening and closing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Laryngeal vestibule opening and closing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Upper esophageal sphincter opening and closing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hyoid horizontal replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: secondary stability of implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Loneliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in skin tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adverse effect after using serum X
Endpoint domain: Adverse events/effects
Primary endpoint: Serum magnesium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Preference for DPP capsule versus two separate tablets
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of DPP capsule versus two separate tablets
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stroop Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in repetitions completed for 30% pre-training 1- Repetition maximum (Single leg Knee extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CFPE index (Capillary to fiber ratio normalized to fiber perimeter)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maximal Citrate synthase (CS) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echocardiographic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiopulmonary testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the cardiac biomarker NTproBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the cardiac biomarker high-sensitivity troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neutrophilic airway inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Early healing of peri-implant soft tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean SES-CD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Banff lesion scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utility Weighted modified Rankin Scale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Extent of brain injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage change in 24-hour urinary protein excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: bacterial detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone calcification markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation Assessment Measure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes of Global cortico-cortical myelination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of the Multiple Sclerosis Functional Composite (MSFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of magnetic resonance imaging (MRI) number of lesions in T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants With a Grade 0 or 1 and a ≥ 2-grade Improvement From Baseline on the FWS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With a ≥ 2-grade Improvement From Baseline on the FWS According to Participant Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health belief scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Brachial artery flow mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Beta2-microglobulin reduction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TNBC
Endpoint domain: Mortality/survival
Primary endpoint: HbA1c Result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patients' reactive behavior to facemask positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CAR-T cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in CAR-T cell copy number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lateral Scapular Slide Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handheld Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Measurements with Scapular Goniometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total volume of local anesthetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuroplasticity of the brain after facial synkinesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hyperexcitability of the pons as a result of synkinesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of PE (%)
Endpoint domain: Adverse events/effects
Primary endpoint: gestational age at delivery (weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinical inspection of the restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penile curvature in erection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Types and incidence of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Successful Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotyping for SNP associated with liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of patients treated with SKYTROFA
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of patients treated with SKYTROFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Sitting Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Sympatholysis Magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiometabolic fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Project acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: M4 receptor occupancy in the striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients continuing treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Exacerbation of COPD episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assessment Test (CAT) scores Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Humoral response to SARS-CoV-2 as measured by neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes of brain functional network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Apical periodontitis healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in gut and lung microbiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gut and lung microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mediators of gut-lung axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Gait and transfer capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of anti-SARS-CoV-2 neutralizing antibody in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of serum anti-SARS-CoV-2 binding antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of anti-SARS-CoV-2 T cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The rate of SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: All other adverse events and toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in multiple symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Symptom and Need for Treatment Scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of switching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in job crafting behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of patients receiving dose intensified infusional 5-FU
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in functional status as assessed by Functional Activity Scoring Tool (FAST)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in functional status as assessed by Patient-Specific Functional Scale (PSFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in functional status as assessed by Knee injury and Osteoarthritis Outcome Score (KOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patients' self-perception of change in their knee condition as assessed by Global Rating of Change Score (GROC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IL-1RA antibodies levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: suPAR levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: % Change in pre- and post test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Allergy symptom changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal air flow changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cure rate of nasopharyngeal necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline caregiving knowledge at 8 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence and severity of procedural and device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of post-operative catheterization after 7 days, up to 14 days
Endpoint domain: Adverse events/effects
Primary endpoint: Change in urinary related symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Circumpapillary retinal nerve fiber layer thickness changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area of the peripapillary area changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Width of the peripapillary area changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total time of spinal anesthesia with hyperbaric bupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of post-operative pain
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of COVID-19 vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes